vs

Side-by-side financial comparison of Axos Financial, Inc. (AX) and U S PHYSICAL THERAPY INC (USPH). Click either name above to swap in a different company.

Axos Financial, Inc. is the larger business by last-quarter revenue ($392.2M vs $202.7M, roughly 1.9× U S PHYSICAL THERAPY INC). Axos Financial, Inc. runs the higher net margin — 31.8% vs 2.0%, a 29.7% gap on every dollar of revenue. Over the past eight quarters, Axos Financial, Inc.'s revenue compounded faster (16.1% CAGR vs 14.1%).

Axos Financial is an American bank holding company based in Las Vegas, Nevada and is the parent of Axos Bank, a direct bank. It also offers registered investment adviser services and an electronic trading platform.

U.S. Physical Therapy Inc. operates hundreds of outpatient physical therapy clinics across the U.S. It offers rehabilitative care for patients recovering from injuries, surgeries, chronic pain and mobility impairments, plus specialized services including sports medicine and pediatric rehabilitation.

AX vs USPH — Head-to-Head

Bigger by revenue
AX
AX
1.9× larger
AX
$392.2M
$202.7M
USPH
Higher net margin
AX
AX
29.7% more per $
AX
31.8%
2.0%
USPH
Faster 2-yr revenue CAGR
AX
AX
Annualised
AX
16.1%
14.1%
USPH

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
AX
AX
USPH
USPH
Revenue
$392.2M
$202.7M
Net Profit
$124.7M
$4.2M
Gross Margin
19.8%
Operating Margin
8.3%
Net Margin
31.8%
2.0%
Revenue YoY
12.3%
Net Profit YoY
18.5%
-55.1%
EPS (diluted)
$2.15
$-0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AX
AX
USPH
USPH
Q1 26
$392.2M
Q4 25
$385.1M
$202.7M
Q3 25
$323.4M
$197.1M
Q2 25
$321.4M
$197.3M
Q1 25
$308.8M
$183.8M
Q4 24
$307.9M
$180.4M
Q3 24
$320.7M
$168.0M
Q2 24
$290.9M
$167.2M
Net Profit
AX
AX
USPH
USPH
Q1 26
$124.7M
Q4 25
$128.4M
$4.2M
Q3 25
$112.4M
$13.1M
Q2 25
$110.7M
$12.4M
Q1 25
$105.2M
$9.9M
Q4 24
$104.7M
$9.2M
Q3 24
$112.3M
$6.6M
Q2 24
$104.9M
$7.5M
Gross Margin
AX
AX
USPH
USPH
Q1 26
Q4 25
19.8%
Q3 25
18.7%
Q2 25
21.1%
Q1 25
16.9%
Q4 24
18.0%
Q3 24
17.3%
Q2 24
20.3%
Operating Margin
AX
AX
USPH
USPH
Q1 26
Q4 25
45.6%
8.3%
Q3 25
46.3%
12.8%
Q2 25
48.5%
12.6%
Q1 25
47.9%
10.7%
Q4 24
48.8%
10.9%
Q3 24
49.6%
7.6%
Q2 24
49.6%
9.3%
Net Margin
AX
AX
USPH
USPH
Q1 26
31.8%
Q4 25
33.3%
2.0%
Q3 25
34.7%
6.7%
Q2 25
34.4%
6.3%
Q1 25
34.1%
5.4%
Q4 24
34.0%
5.1%
Q3 24
35.0%
3.9%
Q2 24
36.0%
4.5%
EPS (diluted)
AX
AX
USPH
USPH
Q1 26
$2.15
Q4 25
$2.22
$-0.44
Q3 25
$1.94
$0.48
Q2 25
$1.89
$0.58
Q1 25
$1.81
$0.80
Q4 24
$1.80
$0.52
Q3 24
$1.93
$0.39
Q2 24
$1.75
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AX
AX
USPH
USPH
Cash + ST InvestmentsLiquidity on hand
$35.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$3.1B
$476.4M
Total Assets
$29.2B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AX
AX
USPH
USPH
Q1 26
Q4 25
$1.0B
$35.6M
Q3 25
$2.6B
$31.1M
Q2 25
$1.9B
$34.1M
Q1 25
$2.0B
$39.2M
Q4 24
$2.4B
$41.4M
Q3 24
$2.6B
$117.0M
Q2 24
$2.0B
$112.9M
Total Debt
AX
AX
USPH
USPH
Q1 26
Q4 25
Q3 25
Q2 25
$312.7M
Q1 25
$377.4M
Q4 24
$358.7M
Q3 24
$313.5M
Q2 24
$325.7M
Stockholders' Equity
AX
AX
USPH
USPH
Q1 26
$3.1B
Q4 25
$2.9B
$476.4M
Q3 25
$2.8B
$503.6M
Q2 25
$2.7B
$500.8M
Q1 25
$2.6B
$497.3M
Q4 24
$2.5B
$488.9M
Q3 24
$2.4B
$482.8M
Q2 24
$2.3B
$484.6M
Total Assets
AX
AX
USPH
USPH
Q1 26
$29.2B
Q4 25
$28.2B
$1.2B
Q3 25
$27.4B
$1.2B
Q2 25
$24.8B
$1.2B
Q1 25
$24.0B
$1.2B
Q4 24
$23.7B
$1.2B
Q3 24
$23.6B
$1.0B
Q2 24
$22.9B
$1.0B
Debt / Equity
AX
AX
USPH
USPH
Q1 26
Q4 25
Q3 25
Q2 25
0.12×
Q1 25
0.14×
Q4 24
0.14×
Q3 24
0.13×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AX
AX
USPH
USPH
Operating Cash FlowLast quarter
$24.9M
Free Cash FlowOCF − Capex
$21.0M
FCF MarginFCF / Revenue
10.4%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
6.00×
TTM Free Cash FlowTrailing 4 quarters
$61.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AX
AX
USPH
USPH
Q1 26
Q4 25
$104.1M
$24.9M
Q3 25
$118.4M
$19.9M
Q2 25
$490.3M
$34.9M
Q1 25
$73.7M
$-4.7M
Q4 24
$162.5M
$19.4M
Q3 24
$70.8M
$22.1M
Q2 24
$305.5M
$29.0M
Free Cash Flow
AX
AX
USPH
USPH
Q1 26
Q4 25
$85.4M
$21.0M
Q3 25
$109.3M
$15.6M
Q2 25
$436.1M
$31.6M
Q1 25
$65.1M
$-7.3M
Q4 24
$156.4M
$16.9M
Q3 24
$53.0M
$19.6M
Q2 24
$269.5M
$26.7M
FCF Margin
AX
AX
USPH
USPH
Q1 26
Q4 25
22.2%
10.4%
Q3 25
33.8%
7.9%
Q2 25
135.7%
16.0%
Q1 25
21.1%
-3.9%
Q4 24
50.8%
9.4%
Q3 24
16.5%
11.7%
Q2 24
92.6%
15.9%
Capex Intensity
AX
AX
USPH
USPH
Q1 26
Q4 25
4.9%
1.9%
Q3 25
2.8%
2.2%
Q2 25
16.9%
1.6%
Q1 25
2.8%
1.4%
Q4 24
2.0%
1.4%
Q3 24
5.5%
1.5%
Q2 24
12.4%
1.4%
Cash Conversion
AX
AX
USPH
USPH
Q1 26
Q4 25
0.81×
6.00×
Q3 25
1.05×
1.52×
Q2 25
4.43×
2.81×
Q1 25
0.70×
-0.47×
Q4 24
1.55×
2.10×
Q3 24
0.63×
3.34×
Q2 24
2.91×
3.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AX
AX

Net Interest Income$306.3M78%
Noninterest Income$86.0M22%

USPH
USPH

Net Patient Revenues$169.7M84%
Industrial Injury Prevention Services Revenues$28.9M14%
Management Contract Revenues$2.3M1%

Related Comparisons